About Michelle M. Tessier

Michelle Tessier represents pharmaceutical companies, medical device manufacturers and food industry clients, litigating complex product-related disputes in multidistrict litigation and large class action cases. She also counsels clients on preventive strategies and risk mitigation. View Michelle's bio on the Faegre Drinker website.

New FDA Policy on Homeopathic Drugs Survives Preliminary Injunction Appeal

Overview

The FDA’s recent policy shift regarding homeopathic drugs was recently supported by the D.C. Circuit Court of Appeals in MediNatura v. FDA, No. 20-5341 (D.C. Cir. 2021), when it upheld the denial of a preliminary injunction to block the FDA from withdrawing a longstanding enforcement policy regarding homeopathic drug products.

Continue reading